Clinical Trial Update: CABI: Antibiotic Duration for Complicated Intra-ABdominal Infection [Phase 2]

View source ↗

Summary

Phase 2 trial update for CABI evaluating antibiotic duration in complicated intra-abdominal infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intraabdominal Infections

Drugs mentioned

• CABI

Snippet

Sponsor: University of Leeds | Conditions: Complicated Intraabdominal Infections | Phase 2 | Status: COMPLETED